Harpreet S. Dhaliwal - 31 Dec 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Signature
Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
31 Dec 2025
Net transactions value
-$454,891
Form type
4
Filing time
02 Jan 2026, 16:21:57 UTC
Previous filing
10 Sep 2025
Next filing
02 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dhaliwal Harpreet S. Chief Technical Ops Officer C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact 02 Jan 2026 0001886794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $454,891 -9,743 -29% $46.69 23,928 31 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.